The challenge of defining “ultra-high-risk” neuroblastoma

1 avr. 2019Pediatric Blood & Cancer

DOI : 10.1002/pbc.27556

Auteurs

Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Dominique Valteau-Couanet, Wendy B. London, Meredith S. Irwin